BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31958191)

  • 1. Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients.
    Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
    Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):208-218. PubMed ID: 31958191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships.
    Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
    Eur J Clin Pharmacol; 2023 Apr; 79(4):553-567. PubMed ID: 36853386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
    Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
    Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
    Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study.
    Spreafico M; Gasperoni F; Barbati G; Ieva F; Scagnetto A; Zanier L; Iorio A; Sinagra G; Di Lenarda A
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):179-190. PubMed ID: 31444666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.
    Greenland M; Knuiman MW; Hung J; Nedkoff L; Arnet I; Rankin JM; Kilkenny MF; Sanfilippo FM
    Sci Rep; 2020 Mar; 10(1):4315. PubMed ID: 32152400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
    Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
    Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operationalization and validation of a novel method to calculate adherence to polypharmacy with refill data from the Australian pharmaceutical benefits scheme (PBS) database.
    Arnet I; Greenland M; Knuiman MW; Rankin JM; Hung J; Nedkoff L; Briffa TG; Sanfilippo FM
    Clin Epidemiol; 2018; 10():1181-1194. PubMed ID: 30233252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.
    Hess LM; Raebel MA; Conner DA; Malone DC
    Ann Pharmacother; 2006; 40(7-8):1280-88. PubMed ID: 16868217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.
    Lu L; Jackevicius CA; de Leon NK; Warner AL; Chang DS; Mody FV
    Clin Ther; 2017 Jun; 39(6):1200-1209. PubMed ID: 28545803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of adherence measures using claims data in the South African private health sector.
    Obeng-Kusi M; Lubbe MS; Cockeran M; Burger JR
    S Afr Med J; 2020 Aug; 110(9):932-936. PubMed ID: 32880281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Medication Adherence and the Outcomes of Heart Failure.
    Hood SR; Giazzon AJ; Seamon G; Lane KA; Wang J; Eckert GJ; Tu W; Murray MD
    Pharmacotherapy; 2018 May; 38(5):539-545. PubMed ID: 29600819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate Medication Adherence Measurement Using Administrative Data for Frequently Hospitalized Patients.
    Rasu RS; Hunt SL; Dai J; Cui H; Phadnis MA; Jain N
    Hosp Pharm; 2021 Oct; 56(5):451-461. PubMed ID: 34720145
    [No Abstract]   [Full Text] [Related]  

  • 14. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients.
    Karve S; Cleves MA; Helm M; Hudson TJ; West DS; Martin BC
    Med Care; 2008 Nov; 46(11):1125-33. PubMed ID: 18953222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: a retrospective cohort study.
    Murphy GK; McAlister FA; Eurich DT
    Can J Cardiol; 2015 Mar; 31(3):341-7. PubMed ID: 25633910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Medication Use and Long-Term Outcomes of First Nations and Non-First Nations Patients Following Diagnostic Angiography: A Retrospective Cohort Study.
    Dahl L; Schultz A; McGibbon E; Brownlie J; Cook C; Elbarouni B; Katz A; Nguyen T; Sawatzky JA; Sinclaire M; Throndson K; Prior HJ; Fransoo R
    J Am Heart Assoc; 2019 Aug; 8(16):e012040. PubMed ID: 31405352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease.
    Hsu CN; Huang SH; Tain YL
    BMC Pediatr; 2019 Feb; 19(1):64. PubMed ID: 30786856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication.
    Martin BC; Wiley-Exley EK; Richards S; Domino ME; Carey TS; Sleath BL
    Ann Pharmacother; 2009 Jan; 43(1):36-44. PubMed ID: 19126828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults.
    Chang TE; Park S; Yang Q; Loustalot F; Butler J; Ritchey MD
    PLoS One; 2019; 14(9):e0222868. PubMed ID: 31545830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.